Literature DB >> 17972252

Why is PTEN an important tumor suppressor?

Li Li1, Alonzo H Ross.   

Abstract

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) was originally cloned as a tumor suppressor for brain tumors. Now it is known as a tumor suppressor for many tumor types. In this review, we ask the simple question: why is PTEN such a common and important tumor suppressor? The most obvious answer is that there are no other family members that can replace PTEN. As a result, several pathways critical for cell transformation are misregulated. The most important of these is the phosphoinositide 3-kinase (P13K) PI3K-Akt pathway, which has downstream effects on transcription, proliferation, cell survival, invasiveness, and angiogenesis. In addition, PTEN is linked via several mechanisms to the p53 tumor suppressor. Through p53 and additional mechanisms, loss of PTEN leads to genomic instability. Hence, PTEN is important because its loss misregulates multiple Akt-dependent and -independent pathways critical for the development of cancer. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972252     DOI: 10.1002/jcb.21593

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  43 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

3.  Phosphorylation keeps PTEN phosphatase closed for business.

Authors:  Alonzo H Ross; Arne Gericke
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

Review 4.  Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.

Authors:  Jiezhong Chen
Journal:  World J Virol       Date:  2012-12-12

5.  Transient silencing of PTEN in human CD34(+) cells enhances their proliferative potential and ability to engraft immunodeficient mice.

Authors:  Inho Kim; Yoo-Jin Kim; Jean-Yves Métais; Cynthia E Dunbar; Andre Larochelle
Journal:  Exp Hematol       Date:  2011-10-20       Impact factor: 3.084

6.  Intratumoral patterns of clonal evolution in gliomas.

Authors:  Ana Luísa Vital; Maria Dolores Tabernero; Inês Crespo; Olinda Rebelo; Hermínio Tão; Fernando Gomes; Maria Celeste Lopes; Alberto Orfao
Journal:  Neurogenetics       Date:  2009-09-17       Impact factor: 2.660

7.  No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer.

Authors:  Lynette S Phillips; Cheryl L Thompson; Alona Merkulova; Sarah J Plummer; Thomas C Tucker; Graham Casey; Li Li
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

8.  Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy.

Authors:  Zorica Milosevic; Nikola Tanic; Jasna Bankovic; Tijana Stankovic; Marko Buta; Dragana Lavrnic; Zorka Milovanovic; Gordana Pupic; Sonja Stojkovic; Vedrana Milinkovic; Yasuhiro Ito; Radan Dzodic
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

9.  PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.

Authors:  Cong Peng; Yaoyu Chen; Zhongfa Yang; Haojian Zhang; Lori Osterby; Alan G Rosmarin; Shaoguang Li
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

10.  Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis.

Authors:  Maria Berndtsson; Emma Hernlund; Maria C Shoshan; Stig Linder
Journal:  J Chem Biol       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.